Related Experiment Video
Updated: May 22, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Uncovering undetected hypoglycemic events.
1Catalina Research Institute, Chino, CA, USA.
Summary
Hypoglycemia, or low blood sugar, is a major barrier for diabetes management, increasing risks for severe complications and impacting patient well-being. Primary care physicians must actively screen for hypoglycemia in all patients on glucose-lowering medications.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Diabetes Management
Background:
- Hypoglycemia (low blood sugar) significantly hinders diabetes treatment goals.
- Severe hypoglycemia is linked to increased risks of macrovascular and microvascular events, and mortality.
- Even minor hypoglycemic episodes negatively affect patient health, psychological state, and treatment adherence.
Purpose of the Study:
- To highlight the multifaceted consequences of hypoglycemia in diabetes management.
- To emphasize the role of primary care physicians in preventing and managing hypoglycemia.
- To underscore the risks associated with insulin therapy and progressive islet cell dysfunction.
Main Methods:
- Review of recent studies on hypoglycemia prevalence and associated risks.
- Analysis of hypoglycemia's impact on patient health, economics, and adherence.
- Discussion of defective counter-regulation and the importance of hypoglycemia awareness.
Main Results:
- Insulin treatment is a key predictor of hypoglycemia, with higher prevalence in both type 1 and type 2 diabetes.
- Patients with type 1 diabetes experience frequent symptomatic and occasional severe hypoglycemia.
- Progressive islet cell dysfunction in type 2 diabetes increases long-term hypoglycemia risk, including unrecognized episodes.
Conclusions:
- Hypoglycemia poses significant risks, including defective counter-regulation (hypoglycemia unawareness), necessitating aggressive management.
- Continuous glucose monitoring and home monitoring are crucial for patients with impaired hypoglycemia recognition.
- Primary care physicians must recognize the risk of iatrogenic hypoglycemia in all patients on antihyperglycemic medications and inquire about it at every visit.
Related Concept Videos
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...